A trial to investigate the effect of nintedanib and pirfenidone in patients with idiopathic pulmonary fibrosis
Latest Information Update: 30 Jun 2016
At a glance
- Drugs Nintedanib (Primary) ; Pirfenidone (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Therapeutic Use
- 30 Jun 2016 New trial record
- 18 May 2016 Results presented at the 112th International Conference of the American Thoracic Society